Back
Mainz Biomed NV 10K Form
Sell
30
MYNZ
Mainz Biomed NV
Last Price:
$1.14
Seasonality Move:
-2.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MYNZ News And Ratings
See the #1 stock for the next 7 days that we like better than MYNZ
MYNZ Financial Statistics
Sales & Book Value
| Annual Sales: | $894K |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-6.47 |
| Price / Book: | 1.87 |
Profitability
| EPS (TTM): | -57.66290 |
|---|---|
| Net Income (TTM): | $-22.5M |
| Gross Margin: | $-442.2K |
| Return on Equity: | -2631.22% |
| Return on Assets: | -350.28% |
Mainz Biomed NV Earnings Forecast
Key Mainz Biomed NV Financial Ratios
-
The Gross Profit Margin over the past 6 years for MYNZ is -49.46%.
-
The Selling, General & Administrative Expenses for MYNZ have been equal to 1,471.38% of Gross Profit Margin.
-
The Research & Development expenses have been 581.79% of Revenue.
-
The Net Earning history of MYNZ is -2,421.78% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Mainz Biomed NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MYNZ |
| Website: | mainzbiomed.com |
Debt
| Debt-to-Equity Ratio: | -1.67 |
|---|---|
| Current Ratio: | 0.24 |
| Quick Ratio: | 0.13 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MYNZ Technical Analysis vs Fundamental Analysis
Sell
30
Mainz Biomed NV (MYNZ)
is a Sell
Is Mainz Biomed NV a Buy or a Sell?
-
Mainz Biomed NV stock is rated a SellThe current Mainz Biomed NV [MYNZ] share price is $1.12. The Score for MYNZ is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.